The Gabelli Healthcare & Wellness Trust is a closed-end investment trust managed by Gabelli Funds, a subsidiary of GAMCO Investors. The trust invests in the healthcare and wellness sectors, utilizing the firm's proprietary Private Market Value With a Catalyst research process to identify companies with strong fundamentals and specific catalysts. It serves institutional and individual clients seeking exposure to the healthcare ecosystem, including pharmaceuticals, biotechnology, and medical devices. The trust operates under the broader Gabelli investment framework, which emphasizes bottom-up fundamental analysis and long-term value creation. While the parent firm offers diverse strategies across equities, fixed income, and convertibles, this specific trust focuses on the healthcare and wellness industry.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Asset Management Homepage gabelli.com
Sector Financial Services IR page gabelli.com/investor-relations
Tags
closed-end fund, healthcare investing, wellness, value investing, equity research, fundamental analysis, institutional investing, individual investing, Gabelli Funds, GAMCO Investors, Private Market Value With a Catalyst, The Gabelli Research Process
Press page gabelli.com/insights/gabelli-media/press-releases

Metrics

Valuation  
Market cap $ 151.142M
P/E 65.87
P/BV 0.95
P/S 50.94
P/OCF -72.19
P/FCF -72.19
Dividend yield —
Turnover / mcap —
Returns  
ROE 1.4%
ROI 1.4%
ROIC 1.4%
Profit margin 77.3%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 25.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2018
Revenue 2.967M 342.909K 1.24M -46.715M 43.491M 0
Free cash flow -2.094M 13.111M 6.607M 58.115M -18.944M —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

As previously announced by GAMCO Investors, Inc. (“GAMCO”) on March 23, 2026, Mario J. Gabelli (“Mr. Gabelli”), Trustee, Chairman and Chief Investment Officer of the Fund, and Chairman, Co-Chief Executive Officer, and Chief Investment Officer – Value Portfolios of GAMCO Investors, Inc. and Chief Investment Officer – Value Portfolios of Gabelli Funds, LLC and GAMCO Asset Management, Inc., was admitted to the hospital for observation and testing after a medical incident March 19, 2026, following a busy day of events around New York City. His condition is improving and he is on the road to recovery, but the timeline for his return is not yet known.

On March 22, 2026, GAMCO, the parent company of the Fund’s adviser, Gabelli Funds, LLC (the “Adviser”), implemented GAMCO’s succession plan that has been in place for several years. In accordance with that plan, Christopher J. Marangi was named President of GAMCO on March 22, 2026.

While the timeline for Mr. Gabelli’s return remains undetermined, the day-to-day operations of GAMCO will continue to be led by co-CEO, Douglas R. Jamieson, and Christopher J. Marangi.

The Gabelli Value team Co-Chief Investment Officers Kevin V.

Prompts

The Gabelli Healthcare & Wellness Trust (ticker GRX), listed in United States.